Prevalence of carbapenemase-encoding genes including New Delhi metallo-β-lactamase in Acinetobacter species, Algeria

International Journal of Infectious Diseases

Volumn 17, Issue 9, 2013, Pages

  Mesli, Esma ^a,b   Berrazeg, Meryem ^a,b   Drissi, Mourad ^b   Bekkhoucha, Souad Naïma ^c   Rolain, Jean Marc ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b UNIVERSITY OF TLEMCEN   (Algeria)

^c HÔpital Universitaire   (Algeria)

Author keywords

Acinetobacter spp; Algeria; NDM 1 producing bacteria

Indexed keywords

AGAR; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CARBAPENEMASE; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM; TICARCILLIN; TOBRAMYCIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; ACINETOBACTER RADIORESISTENS; ALGERIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; DILUTION; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE;

ACINETOBACTER SPP; ALGERIA; NDM-1-PRODUCING BACTERIA;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ALGERIA; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CLUSTER ANALYSIS; HUMANS; PREVALENCE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84881509742     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.02.024     Document Type: Article

References (30)

1. Dijkshoorn L., Nemec A., Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007, 5:939-951.
2. Kempf M., Rolain J.M. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents 2012, 39:105-114.
3. Park S., Kim H.S., Lee K.M., Yoo J.S., Yoo J.I., Lee Y.S., et al. Molecular and epidemiological characterization of carbapenem-resistant Acinetobacter baumannii in non-tertiary Korean hospitals. Yonsei Med J 2013, 54:177-182.
4. Nemec A., Krizova L., Maixnerova M., van der Reijden T.J., Deschaght P., Passet V., et al. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 2011, 162:393-404.
5. Espinal P., Seifert H., Dijkshoorn L., Vila J., Roca I. Rapid and accurate identification of genomic species from the Acinetobacter baumannii (Ab) group by MALDI-TOF MS. Clin Microbiol Infect 2012, 18:1097-1103.
6. Livermore D.M. The impact of carbapenemases on antimicrobial development and therapy. Curr Opin Investig Drugs 2002, 3:218-224.
7. Poirel L., Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006, 12:826-836.
8. Heritier C., Poirel L., Fournier P.E., Claverie J.M., Raoult D., Nordmann P. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother 2005, 49:4174-4179.
9. Turton J.F., Ward M.E., Woodford N., Kaufmann M.E., Pike R., Livermore D.M., Pitt T.L. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006, 258:72-77.
10. Yong D., Toleman M.A., Giske C.G., Cho H.S., Sundman K., Lee K., Walsh T.R. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009, 53:5046-5054.
11. Rolain J.M., Parola P., Cornaglia G. New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?. Clin Microbiol Infect 2010, 16:1699-1701.
12. Wilson M.E., Chen L.H. NDM-1 and the role of travel in its dissemination. Curr Infect Dis Rep 2012, 14:213-226.
13. Livermore D.M., Walsh T.R., Toleman M., Woodford N. Balkan NDM-1: escape or transplant?. Lancet Infect Dis 2011, 11:164.
14. Nordmann P., Poirel L., Walsh T.R., Livermore D.M. The emerging NDM carbapenemases. Trends Microbiol 2011, 19:588-595.
15. Bakour S., Kempf M., Touati A., Ait Ameur A., Haouchine D., Sahli F., Rolain J.M. Carbapenemase-producing Acinetobacter baumannii in two university hospitals in Algeria. J Med Microbiol 2012, 61:1341-1343.
16. Touati M., Diene S.M., Racherache A., Dekhil M., Djahoudi A., Rolain J.M. Emergence of bla(OXA-23) and bla(OXA-58) carbapenemase-encoding genes in multidrug-resistant Acinetobacter baumannii isolates from University Hospital of Annaba, Algeria. Int J Antimicrob Agents 2012, 40:89-91.
17. Kempf M., Bakour S., Flaudrops C., Berrazeg M., Brunel J.M., Drissi M., et al. Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry. PLoS One 2012, 7:e31676.
18. Dalla-Costa L.M., Coelho J.M., Souza H.A., Castro M.E., Stier C.J., Bragagnolo K.L., et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 2003, 41:3403-3406.
19. Paton R., Miles R.S., Hood J., Amyes S.G., Miles R.S., Amyes S.G. ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 1993, 2:81-87.
20. Opazo A., Dominguez M., Bello H., Amyes S.G., Gonzalez-Rocha G. OXA-type carbapenemases in Acinetobacter baumannii in South America. J Infect Dev Ctries 2012, 6:311-316.
21. Poirel L., Figueiredo S., Cattoir V., Carattoli A., Nordmann P. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother 2008, 52:1252-1256.
22. Drissi M., Poirel L., Mugnier P.D., Baba A.Z., Nordmann P. Carbapenemase-producing Acinetobacter baumannii, Algeria. Eur J Clin Microbiol Infect Dis 2010, 29:1457-1458.
23. Lee Y.T., Kuo S.C., Chiang M.C., Yang S.P., Chen C.P., Chen T.L., Fung C.P. Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii. Antimicrob Agents Chemother 2012, 56:1124-1127.
24. Kumarasamy K.K., Toleman M.A., Walsh T.R., Bagaria J., Butt F., Balakrishnan R., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010, 10:597-602.
25. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
26. Boulanger A., Naas T., Fortineau N., Figueiredo S., Nordmann P. NDM-1-producing Acinetobacter baumannii from Algeria. Antimicrob Agents Chemother 2012, 56:2214-2215.
27. Bogaerts P., Rezende de C.R., Roisin S., Deplano A., Huang T.D., Hallin M., et al. Emergence of NDM-1-producing Acinetobacter baumannii in Belgium. J Antimicrob Chemother 2012, 67:1552-1553.
28. Hrabak J., Stolbova M., Studentova V., Fridrichova M., Chudackova E., Zemlickova H. NDM-1-producing Acinetobacter baumannii isolated from a patient repatriated to the Czech Republic from Egypt, July 2011. Euro Surveill 2012, 17. pii: 20085.
29. Sekizuka T., Matsui M., Yamane K., Takeuchi F., Ohnishi M., Hishinuma A., et al. Complete sequencing of the bla(NDM-1)-positive IncA/C plasmid from Escherichia coli ST38 isolate suggests a possible origin from plant pathogens. PLoS One 2011, 6:e25334.
30. Park Y.K., Jung S.I., Park K.H., Cheong H.S., Peck K.R., Song J.H., Ko K.S. Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea. Diagn Microbiol Infect Dis 2009, 64:43-51.